Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-17
Published Online: 2014-06-18
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nishino, Mizuki
Gargano, Maria
Suda, Margaret
Ramaiya, Nikhil H
Hodi, F Stephen
Article History
Received: 12 March 2014
Accepted: 16 April 2014
First Online: 18 June 2014